1.10.8 Autocrine Growth Definition

Autocrine Growth Definition is the precise characterization of a mode of cellular self-stimulation in which a cell secretes a growth factor that then binds to receptors expressed on that same cell, or on neighboring cells of the identical type, thereby stimulating its own proliferation without dependence on growth signals originating from other tissues or cell types. Autocrine growth is defined by the coincidence, within a single cell or clonal population, of both the production of a signaling ligand and the expression of its cognate receptor.

Formally, an autocrine loop is established when a cell expresses the gene encoding a growth factor together with the gene encoding the corresponding receptor, such that secreted ligand can act back upon the secreting cell (or its immediate clonal neighbors) in a closed signaling circuit that does not require external, tissue-supplied input.

Mechanistic Basis of Autocrine Growth

Co-Expression of Ligand and Receptor

The defining molecular requirement for an autocrine loop is simultaneous expression of both the ligand-encoding gene and the receptor-encoding gene within the same cell, a coincidence that is rare in most normal, terminally differentiated cell types but can be acquired through genetic or epigenetic alteration.

Self-Sustaining Signal Propagation

Once established, an autocrine loop is self-reinforcing: continued cell division maintains or increases the number of ligand-and-receptor-expressing cells, which in turn sustains or amplifies the local concentration of the autocrine ligand, perpetuating the proliferative signal.

Independence from Tissue-Level Regulation

Because the signal originates and is received within the same cell population, autocrine growth removes the normal dependence on tissue-level regulatory cues, such as the availability of growth factors from distant sources, allowing proliferation to continue even when the surrounding tissue would not normally support it.

Physiological Occurrence

Transient Autocrine Signaling in Normal Development

Autocrine signaling is not exclusively pathological; it occurs transiently in specific normal physiological contexts, such as during early embryonic development and in certain phases of wound healing, where it provides a temporary, locally amplified proliferative or reparative signal before normal negative feedback and paracrine control are restored.

Relevance to Cancer Biology

Acquisition of Autocrine Loops During Transformation

A recurring event during oncogenic transformation is the acquisition of an autocrine growth loop, in which a cancer cell begins to express both a growth factor and its receptor, examples including autocrine production of platelet-derived growth factor by certain gliomas and autocrine production of transforming growth factor-alpha acting on the epidermal growth factor receptor in some carcinomas.

Contribution to Mitogen Independence

Autocrine growth loops are one of the principal mechanisms by which cancer cells achieve mitogen independence, since the self-produced ligand substitutes for the external mitogenic signals that would otherwise be required, allowing continued proliferation even when the tumor is removed from its normal tissue context or when external growth factor supply is limited.

Therapeutic Relevance

Because autocrine loops depend on a specific ligand-receptor pair, they represent an identifiable and sometimes therapeutically targetable vulnerability, as blocking either the ligand or the receptor can interrupt the self-sustaining proliferative signal.

Distinction from Related Terms

Autocrine signaling is distinguished from paracrine signaling, in which the secreting cell and the responding cell are of different types, and from endocrine signaling, in which the ligand travels through the bloodstream to act on distant tissues. The defining feature of autocrine growth remains the identity, or clonal equivalence, of the secreting and responding cell population.